Certain human traits such as neurodevelopmental disorders (NDs) and congenital anomalies (CAs) 54 are believed to be primarily genetic in origin. With recent dramatic advances in genomic technologies, 55 genome-wide surveys of cohorts of patients with ND/CAs for point mutations and structural variations 56 have greatly advanced our understanding of their genetic etiologies 1,2 . However, even after whole 57 genome sequencing (WGS), a substantial fraction of such disorders remain unexplained 3 . In contrast, 58 the possibility that constitutive epigenetic variations (epivariations) might underlie such traits has not 59 been well explored. We hypothesized that some cases of ND/CA are caused by aberrations of DNA 60 methylation that lead to a dysregulation of normal genome function. By comparing DNA methylation 61 profiles from 489 individuals with ND/CAs against 1,534 population controls, we identified 62 epivariations as a frequent occurrence in the human genome. De novo epivariations were significantly 63 enriched in cases when compared to controls. RNAseq data from population studies showed that 64 epivariations often have an impact on gene expression comparable to loss-of-function mutations. 65
Epimutations represent a class of mutational event where the epigenetic status of a genomic locus 79 deviates significantly from the normal state, and can be classified into two main types: primary 80 epimutations are thought to represent stochastic errors in the establishment or maintenance of an 81 epigenetic state, while secondary epimutations are downstream events related to an underlying 82 change in the DNA sequence 4 . Both secondary and primary epimutations that originate in the 83 germline will be constitutive events found in all cells. In contrast, primary epimutations that occur post-84 fertilization may result in somatic mosaicism. Constitutive (i.e. non-mosaic) epimutations are known to 85 underlie several genetic disorders that can be identified in blood-derived DNA: 5-15% of patients with 86 hereditary non-polyposis colon cancer present with constitutional MLH1 promoter methylation 5 , and 87 fragile X syndrome, the most common cause of inherited intellectual disability, results from a 88 secondary epimutation in which hypermethylation of an expanded CGG repeat at the FMR1 promoter 89 causes transcriptional silencing 6 . 90
We hypothesized that some cases of ND/CA that remain refractory to conventional sequence-91 based analysis harbor rare epigenetic aberrations (termed epivariations) that that are associated with 92 dysregulation of normal genome function. We studied a cohort comprising 489 individuals with 93 ND/CA: most had been previously tested by CNV microarray, all had undergone exome sequencing, 94 and some had undergone WGS, yet no putatively pathogenic mutations had been identified. Almost 95 90% of the patients had a ND, and 65% also had multiple CAs, the majority being congenital heart 96 defects (CHD) ( Supplementary Table 1 ). We hypothesized that this cohort represented an optimal 97 population in which to search for novel pathogenic epivariations since an underlying genomic 98 abnormality was suspected, but many common environmental and genetic causes of ND/CA had 99 been excluded. Methylation profiling in ND/CA samples was performed with the Illumina Infinium 100
HumanMethylation450 BeadChip (450k array). Profiles in each ND/CA sample were compared 101 individually against a control cohort comprising 1,534 unrelated individuals from four publicly available 102 datasets (GSE36064, GSE40279, GSE42861 and GSE53045). We also searched for epivariations in 103 two cohorts of population controls by comparison against this same set of 1,534 individuals: 117 104 families (GSE56105) 7 were used to assess the inheritance of epivariations in controls ( Supplementary Table 2 ); 2,711 unrelated individuals (GSE55763) 8 were used to assess the frequency of epivariations 106 in the general population ( Supplementary Table 3 ). We utilized a sliding window approach to identify 107 epivariations in each sample, defined as 1kb regions containing ≥3 probes showing rare outlier 108 methylation absent in the set of 1,534 common control individuals (see Extended Data Fig. 1 and  109 Online Methods section). After stringent quality control, including removal of loci with clusters of poorly 110 hybridizing probes and extensive manual curation to remove technical and batch effects, we identified 111 a total of 143 epivariations in 114 ND/CA samples (i.e., 23% of the probands tested). Twenty percent 112 of the ND/CA cohort carried one epivariation (n=98), while 3% of the individuals tested presented two 113 or more epivariations (n=16) ( Supplementary Table 4 and Extended Data Fig. 2 ). Using PCR/bisulfite 114 sequencing, we performed orthogonal confirmation for 70 epivariations ( Supplementary Table 5 
137
Epivariations were identified in population controls, and some also occurred in apparently 138 unaffected parents. Thirty three of the 57 DMRs identified in probands for which we investigated 139 inheritance were also present in one parent, and we identified a total of 719 DMRs in the 3,326 control 140 samples analyzed ( Supplementary Tables 2 and 3 ). Twenty four of the epivarations identified in our 141 cases were also present in one or more of these controls, suggesting either that these DMRs are 142 unrelated to the patient phenotype, or perhaps are associated with incomplete penetrance. However, 143
we observed a 1.2 fold enrichment in the frequency of epivariations in the 489 ND/CA samples when 144 compared to 2,711 population controls (Extended Data Fig. 2 ), although this does not reach statistical 145 significance (p=0.058, two-sided Fisher's exact test). Testing of parental samples of 57 ND/CA 146 probands showed that 42% (n=24) of the epivariations were de novo events. When compared to 147 epivariations found in 117 control pedigrees 7 ( Supplementary Table 2 ), this represents a 2.8-fold 148 enrichment in the rate of de novo epivariations in cases compared to controls (p=0.007, two-sided 149
Fisher's exact test) ( Fig. 2) . Thus, while the pathogenic significance of many epivariations is unclear, 150 the paradigm of de novo mutational events echoes that observed for other classes of genetic mutation 151 (copy number and single nucleotide variation) deemed pathogenic in ND and CHD cohorts 9,10 . 152 
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In addition to their de novo nature, recurrence of mutations found in unrelated patients with a 159 similar phenotype is commonly used as a way of assigning significant evidence for the involvement of 160 a specific gene or locus in disease. We identified 12 recurrent epivariations (Extended Data Fig. 3 ), 161
i.e., the same methylation change was identified in multiple unrelated probands. Of these, two 162 epivariations encompassed the promoters of genes with known disease associations (MEG3 and 163 FMR1) 6,11 , showing our approach successfully detects pathogenic epivariations. A third recurrent 164 epivariation coincides with a locus containing a hypermethylated triplet repeat expansion 165 (FRA10AC1) 12 although this, and four other recurrent epivariations detected in our disease cohort, 166
were also identified in population controls, suggesting that they are unlikely to be pathogenic. One of 167 the novel recurrent epivariations detected only in our patient cohort was found in two patients with 168 CHD (Probands 22 and 117), and represents a recurrent hypo-methylation defect at the promoter/5' 169 UTR/first exon of MOV10L1, a gene with an embryonic heart-specific isoform that interacts with the 170 master cardiac transcription factor NKX2.5 13 (Fig. 1 ). Finally, using less stringent criteria for identifying 171
DMRs (see Online Methods), we detected methylation defects in 11 probands at 10 imprinted loci 14 172
(Extended Data Fig. 4 and Supplementary Table 6 ), 90% of which occurred de novo. Of note, we 173 observed loss of methylation at two known imprinted loci that have no prior disease associations 174 (NAA60/ZNF597 in Probands 6 and 62, and L3MBTL1 in Proband 308), although in both cases similar 175 losses of methylation were also observed in population controls, making the pathogenic significance 176 of loss of imprinting at these loci unclear. 177
Based on previous studies 15, 16 , we hypothesized that some epivariations might occur 178 secondarily to an underlying regulatory sequence mutation. In order to identify mutations disrupting 179 regulatory elements (e.g., transcription factor binding sites) that might underlie the methylation 180 changes observed in our cohort, we performed high-resolution array CGH and targeted DNA 181 sequencing of 50 DMRs and their flanking sequences. We detected rare sequence mutations that co-182 segregated with epivariations and potentially impact regulatory elements at 24% of the loci tested: six 183 copy number variations (CNVs) ( Fig. 3 ) and seven single nucleotide variations (SNVs). Where 184 inheritance data from parental samples were available, we found that all of these rare CNVs and 185
SNVs segregated with the presence of the DMR, suggesting that the epivariations occurred 186 secondarily to the underlying sequence mutation. 
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Of the rare segregating SNVs detected at DMRs, three were SNVs within the canonical 198 binding sites for CTCF (CCCTC-binding factor), a transcription factor with roles in chromatin 199 organization (Fig. 4) , including a de novo SNV that disrupts a CTCF binding motif in association with 200 a de novo epivariation (Proband 70) (Extended Data Fig. 5 ). In each case, the disrupted CTCF motif 201 was either overlapping, or very close to (separation <1kb), the DMR. This represents a significant 202 enrichment for rare SNVs disrupting CTCF binding sites in the vicinity of epivariations when compared 203 to the same regions in other sequenced samples who did not carry epivariations at these loci 204 (p=0.0015, two-sided Fisher's exact test), strongly implicating rare cis-linked variants in regulatory 205 sequence as a causative factor underlying some epivariations. Furthermore, given the low frequency 206 of de novo SNVs and epivariations in the genome, it is highly unlikely that a de novo SNV and a de 207 novo epivariation would co-occur at the same locus in an individual by chance, providing additional 208 support that some epivariations represent secondary events caused by disruption of CTCF binding. 209
Using paired methylation and sequence data from 90 individuals studied by the 1000 Genomes 210 project ( Supplementary Table 7 ), we replicated this enrichment for rare SNVs disrupting CTCF 211 binding motifs around epivariations (p=0.049, two-sided Fisher's exact test), identifying two rare 212 CTCF-disrupting SNVs, one of which co-segregates with the presence of an epivariation in multiple 213 unrelated individuals. Though readily detectable by WGS, there is considerable difficulty in 214 interpreting the functional significance of variants outside of coding regions. Thus, we propose that the 215 use of epigenome profiling represents a complementary approach that can provide a rationale for 216 interpreting non-coding genetic variation. 
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In order to provide insight into the biology and functional consequences of epivariations 17 , we 232 performed studies of gene expression, inheritance and tissue conservation using population datasets 233 of DNA methylation ( Supplementary Table 8 ), gene expression ( Supplementary Table 9 ) and 234 genotype data 18-21 . Using paired RNAseq and DNA methylation data in 90 samples from the 1000 235
Genomes Project, we verified that epivariations encompassing gene promoters were often associated 236 with large changes in gene expression, with hypomethylation leading to increased expression and 237 hypermethylation to transcriptional repression, consistent with the known repressive effects of 238 promoter DNA methylation (p=9.2x10 -5 , Wilcoxon Rank-Sum test) (Fig. 5) 22 . We also observed that 239 many hypermethylated epivariations at promoters are associated with complete silencing of one allele 240 (Extended Data Fig. 6) , and, thus, have an impact comparable to that of loss-of-function coding 
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While epigenetic profiles can vary substantially between cell types 23 , it is unclear whether 260 similar cell-specific variability exists for epivariations. To address that, we analyzed cohorts where 261 methylation profiles were available from multiple different tissues 21 . In samples from the GenCord 262 population, in which methylation data from fibroblasts, B cells and T cells are available, by first 263
identifying DMRs in T cells, we observed a very strong concordance for outlier methylation at the 264 same locus in fibroblasts derived from the same individual (Spearman rank correlation of 0.75, 265 p=1.2x10 -27 , Wilcoxon Rank-Sum test) ( Fig. 6 ). Similar concordance for outlier methylation at 266 epivariations was also observed between fibroblasts and B-cells (data not shown). was also observed in a second cohort 24 . Here, epivariations found in blood were nearly all visible in 276 multiple other somatic tissues sampled from the same individual (Extended Data Fig. 7) . Thus, we 277 conclude that the majority of epivariations are constitutive events found in multiple tissues. This 278 provides confidence that epivariations of relevance for ND/CA can be detected using DNA extracted 279 from readily available sources such as peripheral blood leukocytes. 280
Despite strong evidence that some of the epivariations we observed are secondary events 281 related to the presence of an underlying sequence change ( Figs. 3 and 4) , we were unable to detect 282 cis-linked sequence mutations associated with the majority of epivariations in our cohort, suggesting 283 that these might represent primary epivariations that arose sporadically. As the mammalian genome 284 undergoes several rounds of demethylation and remethylation during gametogenesis, embryonic and 285 somatic development 25 , theoretically there is considerable potential for primary epivariations to be 286 reset to the default state. We therefore assessed how often epivariations are stably transmitted 287 between parents and their offspring. Using a large control cohort comprising 117 nuclear families 7 , we 288 studied the heritability of epivariations between generations, identifying 47 epivariations segregating 289 within these pedigrees. We observed a marked deviation from the expectations of Mendelian 290 inheritance, with only 32 instances of parent-child transmission in 95 informative meioses; significantly 291 fewer than the Mendelian expectation of 47.5 transmissions, (p=0.027, two-sided Fisher's exact test) 292
( Supplementary Table 2 ). Therefore, this apparent reduction in heritability indicates that primary 293 epivariations often exhibit non-Mendelian inheritance, and suggests they are frequently reset between 294 generations by epigenetic reprogramming 26, 27 . 295
Our study shows for the first time that epivariations are a relatively common feature in the 296 human genome, that some are associated with changes in local gene expression, and raises the 297 possibility that they may be implicated in the etiology of developmental disorders. In an era when 298 WGS is being applied to many thousands of human genomes, epivariations represent a class of 299 genetic variation that remains undetectable by purely sequence-based approaches. We anticipate that 300 future studies exploring the relationship between sequence variation and epigenetic state will further 301 illuminate the regulatory architecture of the human genome, providing novel insight into the 302 consequences of non-coding mutations. 303 304
